LightPath Announces Availability of a New Version of Its Mantis Camera for Long Range Detection
UF Innovate | Accelerate startup company LightPath Technologies, Inc., a leading global manufacturer and integrator of proprietary optical and infrared technologies, recently announced the availability of a new camera that utilizes its innovative Mantis™ Camera architecture, designed for long distance imaging.
UF Neuro Research Ranks No. 2 Nationally in NIH Funding
Neuroscience and neuromedicine research at the University of Florida ranked No. 2 in NIH funding among all public universities in the U.S., according to the Blue Ridge Institute for Medical Research’s 2023 rankings. With $31.8 million in NIH funding, UF neurosciences — a combined ranking of the departments of neuroscience and neurology — ranked No. 2 among public universities and No. 3 overall. In 2022, UF neurosciences ranked No. 3 among public universities and No. 5 overall.
Tech Tuesday – Felipe Ferrão
In this week’s Tech Tuesday for WCJB TV20, UF Innovate’s Loren Miranda speaks with Felipe Ferrão, associate research scientist the University of Florida Institute of Food and Agricultural Sciences finding ways to make coffee a go-to crop for Florida farmers.
Decoding the Genes Behind Dolastatin 10 Paves the Way for New Cancer Therapeutics
Researchers at the University of Florida College of Pharmacy have identified the genes responsible for the creation of dolastatin 10, a marine natural product that has led to six FDA-approved cancer drugs since 2011. The research team used genomic library screening and genome sequencing to identify the genes responsible for producing the marine natural product.
Novel Compound Opens New Avenue in Immunotherapy Treatment for Cancers
Researchers at the UF Health Cancer Center have developed a first-of-it-kind compound that may reveal a new way to treat cancer using immunotherapy. Currently, immunotherapy is among the most groundbreaking cancer treatments, but only about 20% to 40% of patients respond to it. It works by first identifying a target protein that contributes to tumor development and then developing a compound that will target that protein specifically, slowing tumor growth and boosting the body's immune system to fight off the cancer.
Christine Schmidt elected to National Academy of Engineering
UF Distinguished Professor Christine Schmidt, Ph.D., has been elected to the National Academy of Engineering. Dr. Schmidt has been working in the field for over 25 years, helping to advance the fields of neural tissue engineering and helping diversify the field of bioengineering. Serving for 10 years as the department chair in the J. Crayton Pruitt Family Department of Biomedical Engineering, Dr. Schmidt pushed the UF BME graduate program to the No. 12 ranked public graduate program in the nation while diversifying the program and producing cutting-edge research.
Dr. Castillo Caro Accepted into Early Investigator Advancement Program
Paul Castillo, M.D., was recently accepted into the National Cancer Institute's Early Investigator Advancement Program. The program aims to bolster expertise and offer guidance for investigators to create competitive grant applications.
UF/IFAS Scientists Address Food Security in the Caribbean
Jehangir 'Jango' Bhadha, associate professor of soil, water, and ecosystem sciences at the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS), recently led a team of faculty during a three-day training program in Saint Vincent and the Grenadines to address the challenges of excess and lack of nutrients used for agricultural production.
Oragenics, Inc. Preparing for Phase II Clinical Trials To Treat Concussion
UF Innovate | Accelerate Sid Martin graduate company Oragenics announced the approval of Phase II clinical trials for their novel drug-device aimed at treating mild Traumatic Brain Injury, or concussion. The drug is delivered to patients as a powder through the nose, and Phase I studies showed the drug to be safe and well-tolerated. In animal testing, the drug improved behavioral outcomes including memory and motor performance in subjects with brain injuries.
Tech Tuesday – Barry Byrne
In this week’s Tech Tuesday for WCJB TV20, UF Innovate’s Loren Miranda speaks with Dr. Barry Byrne, Associate Chair of Pediatrics and Director of the UF Powell Gene Therapy Center.
